EHRA Premium Access

Is there a role for anti-arrhythmic drugs or catheter ablation?

Presentation

About the speaker

Professor Frank Ruschitzka

University Heart Center, Zurich (Switzerland)
81 presentations
2 followers

3 more presentations in this session

The impact of atrial fibrillation in HFREF and HFPEF

Speaker: Professor A. Coats (Coventry, GB)

Thumbnail

Permanent atrial fibrillation in HFREF and HFPEF: when and how to control rate?

Speaker: Professor D. Kotecha (Birmingham, GB)

Thumbnail

The mitral valve in patients with AF and HF - Do we need specific therapy?

Speaker: Professor R. Rosenhek (Vienna, AT)

Thumbnail

Access the full session

New insights on atrial fibrillation in patients with HFrEF and HFpEF: treatment strategies to optimise outcome

Speakers: Professor F. Ruschitzka, Professor A. Coats, Professor D. Kotecha, Professor R. Rosenhek
Thumbnail

About the event

Image

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk